• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Tuesday

    7/18/23 1:47:52 PM ET
    $ABVC
    $ALT
    $APLS
    $AREB
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ABVC alert in real time by email

     

    During Tuesday's trading, 46 companies set new 52-week lows.

    Interesting Highlights From Today's 52-Week Lows:

    • The largest company by market cap to set a new 52-week low was TELUS (NYSE:TU).
    • American Rebel Holdings (NASDAQ:AREB) was the smallest firm on a market cap basis to set a new 52-week low.
    • 9 Meters Biopharma (NASDAQ:NMTR) was the biggest loser, trading down 68.25% to reach its 52-week low.
    • Shuttle Pharmaceuticals (NASDAQ:SHPH) saw the sharpest rebound, as shares ascended 0.0%, reversing after hiting a new 52-week low.

    The stocks that set new 52-week lows on Tuesday:

    • Masimo (NASDAQ:MASI) stock drifted down 21.85% on Tuesday morning to hit a new 52-week low of $105.50.
    • Apellis Pharmaceuticals (NASDAQ:APLS) stock dropped to a yearly low on Tuesday of $40.04. Shares traded down 18.68%.
    • TELUS Intl (NYSE:TIXT) stock achieved a new 52-week low on Tuesday morning, hitting $9.65 and moving down 1.62%.
    • Mirati Therapeutics (NASDAQ:MRTX) shares set a new yearly low of $33.95 this morning. The stock was down 1.33% on the session.
    • Lumen Technologies (NYSE:LUMN) stock achieved a new 52-week low on Tuesday morning, hitting $1.67 and moving down 0.92%.
    • Nu Skin Enterprises (NYSE:NUS) shares made a new 52-week low of $28.59 on Tuesday. The stock was up 1.88% for the day.
    • Embecta (NASDAQ:EMBC) shares set a new yearly low of $19.91 this morning. The stock was down 1.06% on the session.
    • Leslies (NASDAQ:LESL) shares fell to $5.35 on Tuesday, setting a new 52-week low with a shift of up 5.31%.
    • SIGNA Sports United (NYSE:SSU) shares set a new yearly low of $2.59 this morning. The stock was up 0.76% on the session.
    • Mondee Hldgs (NASDAQ:MOND) stock broke to a new 52-week low of $6.42 on Tuesday. Shares of the company traded down 6.27%.
    • Enanta Pharma (NASDAQ:ENTA) shares set a new yearly low of $18.50 this morning. The stock was up 1.54% on the session.
    • Karyopharm Therapeutics (NASDAQ:KPTI) shares reached a new 52-week low of $1.46 on Tuesday morning, moving up 0.98%.
    • Altimmune (NASDAQ:ALT) shares moved up 1.41% on Tuesday to hit a new 52-week low of $3.12, drifting up 1.41%.
    • OrganiGram Holdings (NASDAQ:OGI) shares reached a new 52-week low of $1.43 on Tuesday morning, moving down 0.79%.
    • Ohmyhome (NASDAQ:OMH) stock broke to a new 52-week low of $2.87 on Tuesday. Shares of the company traded down 7.86%.
    • RVL Pharmaceuticals (NASDAQ:RVLP) shares reached a new 52-week low of $0.41 on Tuesday morning, moving down 7.91%.
    • FLJ Group (NASDAQ:FLJ) stock broke to a new 52-week low of $0.20 on Tuesday. Shares of the company traded down 2.36%.
    • CalAmp (NASDAQ:CAMP) stock broke to a new 52-week low of $0.92 on Tuesday. Shares of the company traded down 1.65%.
    • Yunji (NASDAQ:YJ) stock hit a new 52-week low of $1.25. The stock was down 4.55% on the session.
    • Salem Media Group (NASDAQ:SALM) stock set a new 52-week low of $0.88 on Tuesday, moving down 0.03%.
    • AERWINS Technologies (NASDAQ:AWIN) stock dropped to a yearly low on Tuesday of $0.35. Shares traded down 21.36%.
    • 60 Degrees (NASDAQ:SXTP) stock hit $2.61 on Tuesday morning, setting a new 52-week low for a change of down 9.77%.
    • Fangdd Network Group (NASDAQ:DUO) shares moved down 33.67% on Tuesday to hit a new 52-week low of $0.25, drifting down 33.67%.
    • Shuttle Pharmaceuticals (NASDAQ:SHPH) stock drifted 0.0% (flat) on Tuesday morning to hit a new 52-week low of $0.98.
    • Greenbrook TMS (NASDAQ:GBNH) shares moved down 19.27% on Tuesday to hit a new 52-week low of $0.33, drifting down 19.27%.
    • EUDA Health Holdings (NASDAQ:EUDA) shares set a new 52-week low of $0.48. The stock traded down 21.1%.
    • GRI Bio (NASDAQ:GRI) shares made a new 52-week low of $3.67 on Tuesday. The stock was up 6.33% for the day.
    • ABVC BioPharma (NASDAQ:ABVC) shares moved down 7.49% on Tuesday to hit a new 52-week low of $0.34, drifting down 7.49%.
    • Marpai (NASDAQ:MRAI) shares were down 3.9% for the day, having made a 52-week low of $1.52.
    • Powerbridge Technologies (NASDAQ:PBTS) stock hit $0.33 on Tuesday morning, setting a new 52-week low for a change of down 4.87%.
    • T Stamp (NASDAQ:IDAI) stock achieved a new 52-week low on Tuesday morning, hitting $0.77 and moving down 4.23%.
    • Spark Networks (NASDAQ:LOV) shares set a new yearly low of $0.21 this morning. The stock was down 6.45% on the session.
    • Integrated Media Tech (NASDAQ:IMTE) stock drifted down 6.83% on Tuesday morning to hit a new 52-week low of $0.25.
    • SuperCom (NASDAQ:SPCB) shares were down 1.1% for the day, having made a 52-week low of $0.92.
    • First Wave BioPharma (NASDAQ:FWBI) shares moved down 13.6% on Tuesday to hit a new 52-week low of $0.67, drifting down 13.6%.
    • 9 Meters Biopharma (NASDAQ:NMTR) shares reached a new 52-week low of $0.18 on Tuesday morning, moving down 68.25%.
    • Galmed Pharmaceuticals (NASDAQ:GLMD) shares set a new 52-week low of $1.31. The stock traded down 1.47%.
    • Biocept (NASDAQ:BIOC) shares were down 3.52% for the day, having made a 52-week low of $1.10.
    • American Rebel Holdings (NASDAQ:AREB) shares moved up 2.79% on Tuesday to hit a new 52-week low of $1.80, drifting up 2.79%.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $ABVC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABVC
    $ALT
    $APLS
    $AREB

    CompanyDatePrice TargetRatingAnalyst
    Altimmune Inc.
    $ALT
    4/24/2026$2.50Sell → Neutral
    Goldman
    CAMP4 Therapeutics Corporation
    $CAMP
    4/14/2026$7.00Buy
    Rodman & Renshaw
    Telus Corporation
    $TU
    4/9/2026Buy → Hold
    Canaccord Genuity
    Telus Corporation
    $TU
    4/3/2026Buy → Hold
    TD Securities
    Telus Corporation
    $TU
    4/2/2026Buy → Hold
    TD Securities
    Masimo Corporation
    $MASI
    3/27/2026Outperform → Mkt Perform
    Raymond James
    Enanta Pharmaceuticals Inc.
    $ENTA
    3/26/2026$20.00Buy
    Rodman & Renshaw
    Altimmune Inc.
    $ALT
    3/18/2026$12.00Buy
    Truist
    More analyst ratings

    $ABVC
    $ALT
    $APLS
    $AREB
    SEC Filings

    View All

    SEC Form 20-F filed by Yunji Inc.

    20-F - Yunji Inc. (0001759614) (Filer)

    4/24/26 6:32:51 AM ET
    $YJ
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 6-K filed by Ohmyhome Limited

    6-K - Ohmyhome Ltd (0001944902) (Filer)

    4/24/26 6:30:20 AM ET
    $OMH
    Real Estate
    Finance

    SEC Form 424B5 filed by Altimmune Inc.

    424B5 - Altimmune, Inc. (0001326190) (Filer)

    4/23/26 9:29:55 PM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABVC
    $ALT
    $APLS
    $AREB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Weaver Gregory L bought $17,700 worth of shares (5,000 units at $3.54), increasing direct ownership by 22% to 28,078 units (SEC Form 4)

    4 - Altimmune, Inc. (0001326190) (Issuer)

    3/9/26 7:05:04 AM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President and CEO Durso Jerome Benedict bought $70,790 worth of shares (20,000 units at $3.54), increasing direct ownership by 160% to 32,500 units (SEC Form 4)

    4 - Altimmune, Inc. (0001326190) (Issuer)

    3/9/26 7:00:05 AM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President & CEO Johnson Kathleen E bought $499,925 worth of shares (78,685 units at $6.35), increasing direct ownership by 0.93% to 8,562,582 units (SEC Form 4)

    4 - Lumen Technologies, Inc. (0000018926) (Issuer)

    2/5/26 5:34:09 PM ET
    $LUMN
    Telecommunications Equipment
    Telecommunications

    $ABVC
    $ALT
    $APLS
    $AREB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Yunji Files 2025 Annual Report on Form 20-F

    HANGZHOU, China, April 24, 2026 /PRNewswire/ -- Yunji Inc. ("Yunji" or the "Company") (NASDAQ:YJ), a leading membership-based social e-commerce platform, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the Securities and Exchange Commission on April 24, 2026 Eastern Time. The annual report can be accessed on the Company's investor relations website at https://investor.yunjiglobal.com. The Company will provide a hard copy of its annual report containing the audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request. Requests should be submitted to [email protected] Yunji

    4/24/26 7:30:00 AM ET
    $YJ
    Other Specialty Stores
    Consumer Discretionary

    What Analyst Rankings and Enterprise Procurement Teams Reveal About Choosing an AI Data Partner for Robotics

    Robotics programs require egocentric, multi-sensor training data at a scale that is growing exponentially, creating a procurement challenge distinct from any prior AI development cycle Annotation standards for robotics remain fragmented, with no universally accepted benchmarks comparable to the SAE J3016 framework that matured the autonomous vehicle data industry Enterprise procurement teams evaluating physical AI data partners are converging on five dimensions: sensor coverage, scale, quality systems, domain expertise and compliance certifications Managed annotation services reduce program risk for physical AI applications in ways that self-service platforms are not designed to address VAN

    4/24/26 7:00:00 AM ET
    $TU
    Telecommunications Equipment
    Telecommunications

    Lumen Technologies to Participate in Upcoming Investor Conferences

    Lumen Technologies (NYSE:LUMN), the trusted network for AI, will attend the following investor conferences during the second quarter of 2026: JP Morgan Global Tech Conference on May 18. TD Cowen Technology, Media & Telecom Conference on May 27. When applicable, live webcast links to investor presentations will be available on the Lumen Investor Relations website. About Lumen Technologies Lumen is unleashing the world's digital potential. We ignite business growth by connecting people, data, and applications – quickly, securely, and effortlessly. As the trusted network for AI, Lumen uses the scale of our network to help companies realize AI's full potential. From metro connectiv

    4/23/26 4:05:00 PM ET
    $LUMN
    Telecommunications Equipment
    Telecommunications

    $ABVC
    $ALT
    $APLS
    $AREB
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for KRAZATI issued to MIRATI THERAPEUTICS, INC

    Submission status for MIRATI THERAPEUTICS, INC's drug KRAZATI (ORIG-1) with active ingredient ADAGRASIB has changed to 'Approval' on 12/12/2022. Application Category: NDA, Application Number: 216340, Application Classification: Type 1 - New Molecular Entity

    12/14/22 7:40:10 AM ET
    $MRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for KRAZATI (ADAGRASIB) issued to MIRATI THERAPEUTICS, INC

    Submission status for MIRATI THERAPEUTICS, INC's drug KRAZATI (ADAGRASIB) (ORIG-1) with active ingredient ADAGRASIB has changed to 'Approval' on 12/12/2022. Application Category: NDA, Application Number: 216340, Application Classification: Type 1 - New Molecular Entity

    12/12/22 6:09:02 PM ET
    $MRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for KRAZATI (ADAGRASIB) issued to MIRATI THERAPEUTICS, INC

    Submission status for MIRATI THERAPEUTICS, INC's drug KRAZATI (ADAGRASIB) (ORIG-1) with active ingredient ADAGRASIB has changed to 'Approval' on 12/12/2022. Application Category: NDA, Application Number: 216340, Application Classification: Efficacy

    12/12/22 4:56:01 PM ET
    $MRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABVC
    $ALT
    $APLS
    $AREB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Hodges Jennifer A.

    4 - Lumen Technologies, Inc. (0000018926) (Issuer)

    4/22/26 5:52:48 PM ET
    $LUMN
    Telecommunications Equipment
    Telecommunications

    SEC Form 3 filed by new insider Hodges Jennifer A.

    3 - Lumen Technologies, Inc. (0000018926) (Issuer)

    4/22/26 5:51:23 PM ET
    $LUMN
    Telecommunications Equipment
    Telecommunications

    SEC Form 4 filed by Rangwala Reshma

    4 - Karyopharm Therapeutics Inc. (0001503802) (Issuer)

    4/22/26 4:03:38 PM ET
    $KPTI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABVC
    $ALT
    $APLS
    $AREB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Altimmune upgraded by Goldman with a new price target

    Goldman upgraded Altimmune from Sell to Neutral and set a new price target of $2.50

    4/24/26 7:59:47 AM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Rodman & Renshaw initiated coverage on CAMP4 Therapeutics with a new price target

    Rodman & Renshaw initiated coverage of CAMP4 Therapeutics with a rating of Buy and set a new price target of $7.00

    4/14/26 8:19:24 AM ET
    $CAMP

    Telus downgraded by Canaccord Genuity

    Canaccord Genuity downgraded Telus from Buy to Hold

    4/9/26 8:34:14 AM ET
    $TU
    Telecommunications Equipment
    Telecommunications

    $ABVC
    $ALT
    $APLS
    $AREB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Fangdd Network Group Ltd.

    SC 13G - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:26:40 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13G/A filed by Fangdd Network Group Ltd.

    SC 13G/A - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:24:27 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13D/A filed by Organigram Holdings Inc.

    SC 13D/A - ORGANIGRAM HOLDINGS INC. (0001620737) (Subject)

    12/10/24 7:10:15 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABVC
    $ALT
    $APLS
    $AREB
    Leadership Updates

    Live Leadership Updates

    View All

    Lumen Appoints Jim Ortbals Senior Vice President of Global Partner Solutions

    New senior leader to strengthen channel partner execution, simplify partner motions, and scale outcomes for enterprise customers Lumen Technologies (NYSE:LUMN) today announced that Jim Ortbals will join the company as Senior Vice President of Global Partner Solutions (GPS). Ortbals will lead Lumen's channel partner strategy and execution, with responsibility for strengthening how the company engages, enables, and scales outcomes through this critical part of its commercial approach. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413468127/en/Lumen Senior Vice President of Global Partner Solutions Jim Ortbals "As we transfor

    4/13/26 12:05:00 PM ET
    $LUMN
    Telecommunications Equipment
    Telecommunications

    Organigram Announces Shareholder Approval of Acquisition of Sanity Group GmbH and Results of its Annual General and Special Meeting

    Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), is pleased to announce that the shareholders of Organigram have overwhelmingly approved the resolution required to consummate the previously announced acquisition by the Company (the "Transaction") of Sanity Group GmbH ("Sanity Group") and the related private placement financing (the "Private Placement") with BT DE Investments Inc., a wholly-owned subsidiary of British American Tobacco ("BAT") at the Company's annual general and special meeting of shareholders (the "Shareholders") held on March 30, 2026 (the "Meeting"). Shareholders approved an ordinary resolution (the "Transaction Resolution") authorizing (i)

    3/30/26 8:30:00 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CAMP4 Appoints Michael MacLean to its Board of Directors

    CAMBRIDGE, Mass., March 24, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation ("CAMP4" or "the Company") (NASDAQ:CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of genetic diseases, today announced the appointment of Michael MacLean to the Company's Board of Directors. "Mike brings an exceptional depth of financial and operational expertise built across decades of leadership at some of the most innovative biotechnology companies, and we are thrilled to welcome him to CAMP4's Board," said Josh Mandel-Brehm, Pr

    3/24/26 7:00:00 AM ET
    $CAMP

    $ABVC
    $ALT
    $APLS
    $AREB
    Financials

    Live finance-specific insights

    View All

    SuperCom to Report Fourth Quarter and Full Year 2025 Financial Results on April 28th, 2026

    TEL AVIV, Israel, April 23, 2026 /PRNewswire/ -- SuperCom (NASDAQ:SPCB), a global provider of secured solutions for the e-Government, IoT and Cybersecurity sectors, will hold a conference call on Tuesday, April 28, 2026, at 10 a.m. Eastern time (7 a.m. Pacific Time / 5 p.m. IL time) to discuss its financial results for the fourth quarter and year ended December 31, 2025. Financial results will be issued in a press release prior to the call. SuperCom management will host the conference call, followed by a question-and-answer period.Conference Call Dial-In Information:Date: Tuesday, April 28, 2026Time: 10 a.m. Eastern time (7 a.m. Pacific time)U.S. toll-free: 888-506-0062Israel toll-free: 1-80

    4/23/26 9:28:00 AM ET
    $SPCB
    Semiconductors
    Technology

    embecta to Report Fiscal Second Quarter Financial Results

    PARSIPPANY, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call to discuss its fiscal second quarter 2026 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Tuesday, May 5, 2026. Those who would like to participate may access the live webcast here, or access the teleconference here. The live webcast can also be accessed via the company's website at investors.embecta.com. A webcast replay of the call will be available beginning at 11:00

    4/21/26 5:00:00 PM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    Lumen Technologies to Hold First Quarter 2026 Earnings Conference Call

    Lumen Technologies (NYSE:LUMN), the trusted network for AI, today announced that it will publish its first quarter financial results following market close on May 5, 2026. A live broadcast of the earnings conference call will be available on the company's Investor Relations website at 5:00 pm. ET. Additional information regarding the first quarter 2026 results, including the company's earnings release, investor presentation, and related materials, will be available on Lumen's Investor Relations website. About Lumen Lumen is unleashing the world's digital potential. We ignite business growth by connecting people, data, and applications – quickly, securely, and effortlessly. As the trus

    4/14/26 4:05:00 PM ET
    $LUMN
    Telecommunications Equipment
    Telecommunications